Are paid speaker programs worth the risk?

Crystal Singleton (crystal.m.singleton@osfhealthcare.org) is Vice President, Compliance Services, at OSF Healthcare System in Peoria, IL.

In a rare move, the U.S. Department of Health & Human Services Office of Inspector General (OIG) issued a special fraud alert on speaker programs on November 16, 2020.[1] The alert warns the provider, pharmaceutical, and medical device industries of the risks associated with payments for speaker programs. Speaker programs are company-sponsored events where physicians or other healthcare professionals (collectively, HCPs) make speeches or presentations to other HCPs about a drug, device product, or disease state on behalf of the company. The company generally pays the speakers an honorarium, and attendees often receive remunerations such as free meals.

The timing of the announcement amid the various stay-at-home orders and cancellations is ironic yet telling of what we can expect from the OIG as the industry begins to reemerge into the world of educational events, travel, and conferences. OIG acknowledges that the pandemic has “necessarily curtail[ed]” many in-person activities but clarifies that the “risks remain whenever payments are offered or made to HCPs who generate Federal health care program business.” This statement by the OIG clearly signals that virtual events are within the scope of the alert’s guidance.

This document is only available to members. Please log in or become a member.
 


Would you like to read this entire article?

If you already subscribe to this publication, just log in. If not, let us send you an email with a link that will allow you to read the entire article for free. Just complete the following form.

* required field